SCHEMBL6667006

SCHEMBL6667006

Cc1cc(C(=O)Nc2ccc3c(c2)CCN3C(=O)Cc2ccccn2)c(-c2ccccc2)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 11/20 0.49
HTR2B P41595 8/20 0.49
EIF2AK3 Q9NZJ5 1/20 0.46
SMO Q99835 1/20 0.44
NPY2R P49146 1/20 0.42
HTR2A P28223 9/20 0.42
MAPT P10636 1/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664668 0.97 HTR2C (0.49) HTR2CHTR2BEIF2AK3SMONPY2R
SCHEMBL6668816 0.90 EIF2AK3 (0.45) HTR2CHTR2BEIF2AK3SMONPY2R
SCHEMBL6664595 0.89 EIF2AK3 (0.45) HTR2CHTR2BEIF2AK3SMOHTR2A
SCHEMBL6664767 0.89 EIF2AK3 (0.46) HTR2CHTR2BEIF2AK3SMONPY2R
SCHEMBL6670489 0.89 EIF2AK3 (0.49) HTR2CHTR2BEIF2AK3SMOHTR2A
SCHEMBL6665469 0.88 EIF2AK3 (0.45) HTR2CHTR2BEIF2AK3SMONPY2R
SCHEMBL6665112 0.88 HTR2C (0.46) HTR2CHTR2BEIF2AK3SMONPY2R
SCHEMBL6667059 0.88 EIF2AK3 (0.48) HTR2CHTR2BEIF2AK3SMOHTR2A
SCHEMBL6664878 0.88 EIF2AK3 (0.48) HTR2CHTR2BEIF2AK3SMOHTR2A
SCHEMBL6667948 0.88 EIF2AK3 (0.45) HTR2CHTR2BEIF2AK3SMOHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383760-A1 BIARYLCARBOXAMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-01-28 EP disclosed
WO-2002090347-A1 AMIDE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-14 WO disclosed